Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 13(9): e0202833, 2018.
Article in English | MEDLINE | ID: mdl-30180177

ABSTRACT

Bone is a highly organized tissue in which each structural level influences the macroscopic and microscopic mechanical behavior. In particular, the quantity, quality, and distribution of the different bone components, i.e. collagen matrix and hydroxyapatite crystals, are associated with bone strength or fragility. Common spectroscopic techniques used to assess bone composition have resolutions limited to the micrometer range. In this study, our aims were two-fold: i) to develop and validate the AFM-IR methodology for skeletal tissues and ii) to apply the methodology to sheep cancellous bone with the objective to obtain novel findings on the composition and structure of trabecular packets.To develop the methodology, we assessed spatial and temporal reproducibility using a known homogeneous material (polymethylmethacrylate, PMMA). We verified that the major peak positions were similar and not shifted when compared to traditional Fourier Transform Infrared imaging (FTIRI). When AFM-IR was applied to sheep cancellous bone, the mineral-to-matrix ratio increased and the acid phosphate substitution ratio decreased as a function of tissue maturity. The resolution of the technique enabled visualization of different stages of the bone maturation process, particularly newly-formed osteoid prior to mineralization. We also observed alternating patterns of IR parameters in line and imaging measurements, suggesting the apposition of layers of alternating structure and / or composition that were not visible with traditional spectroscopic methods. In conclusion, nanoscale IR spectroscopy demonstrates novel compositional and structural changes within trabecular packets in cancellous bone. Based on these results, AFM-IR is a valuable tool to investigate cancellous bone at the nanoscale and, more generally, to analyze small dynamic areas that are invisible to traditional spectroscopic methods.


Subject(s)
Cancellous Bone/chemistry , Cancellous Bone/diagnostic imaging , Nanotechnology/methods , Spectroscopy, Fourier Transform Infrared/methods , Animals , Bone Matrix/chemistry , Bone Matrix/diagnostic imaging , Bone Matrix/drug effects , Calcification, Physiologic/drug effects , Cancellous Bone/drug effects , Collagen/chemistry , Durapatite/chemistry , Microscopy, Energy-Filtering Transmission Electron , Polymethyl Methacrylate/chemistry , Polymethyl Methacrylate/pharmacology , Reproducibility of Results , Sheep
2.
Biochem Biophys Res Commun ; 419(2): 333-8, 2012 Mar 09.
Article in English | MEDLINE | ID: mdl-22342723

ABSTRACT

The manuscript tests the hypothesis that posttranslational modification of the SIBLING family of proteins in general and osteopontin in particular modify the abilities of these proteins to regulate in vitro hydroxyapatite (HA) formation. Osteopontin has diverse effects on hydroxyapatite (HA) mineral crystallite formation and growth depending on the extent of phosphorylation. We hypothesized that different regions of full-length OPN would also have distinct effects on the mineralization process. Thrombin fragmentation of milk OPN (mOPN) was used to test this hypothesis. Three fragments were tested in a de novo HA formation assay; an N-terminal fragment (aa 1-147), a central fragment (aa 148-204) denoted SKK-fragment and a C-terminal fragment (aa 205-262). Compared to intact mOPN the C- and N-terminal fragments behaved comparably, promoting HA formation and growth, but the central SKK-fragment acted as a mineralization inhibitor. In a seeded growth experiment all fragments inhibited mineral proliferation, but the SKK-fragment was the most effective inhibitor. These effects, seen in HA-formation and seeded growth assays in a gelatin gel system and in a pH-stat experiment were lost when the protein or fragments were dephosphorylated. Effects of the fully phosphorylated protein and fragments were also altered in the presence of fibrillar collagen. The diverse effects can be explained in terms of the intrinsically disordered nature of OPN and its fragments which enable them to interact with their multiple partners.


Subject(s)
Durapatite/chemical synthesis , Milk Proteins/chemistry , Osteopontin/chemistry , Protein Processing, Post-Translational , Amino Acid Sequence , Animals , Cattle , Collagen/chemistry , Molecular Sequence Data , Thrombin/chemistry
3.
Calcif Tissue Int ; 86(1): 42-6, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19998030

ABSTRACT

Matrix extracellular phosphoglycoprotein (MEPE) is an inhibitor of mineralization in situ and in cell cultures where altered expression is associated with oncogenic osteomalacia and hypophosphatemic rickets. The purpose of this study was to determine whether the intact protein or the peptide(s) originating from this protein was responsible for the inhibition. The ability of the intact protein and the acidic, serine- and aspartate-rich MEPE-associated motif (ASARM) peptide to promote or inhibit de novo hydroxyapatite formation and growth of hydroxyapatite seed crystals, in both phosphorylated and dephosphorylated forms, was assessed at room temperature in a dynamic gel diffusion system at 3.5 and 5 days. The most effective nucleator concentration was also examined when associated with fibrillar type I collagen. The phosphorylated intact protein was an effective promoter of mineralization in the gelatin gel diffusion system, while the ASARM peptide was an effective inhibitor. When dephosphorylated both the intact protein and the ASARM peptide had no effect on mineralization. Associated with collagen fibrils, some of the effect of the intact protein was lost. This study demonstrates the importance of posttranslational modification for the site-specific activity of MEPE and its ASARM peptide.


Subject(s)
Bone and Bones/metabolism , Calcification, Physiologic/physiology , Durapatite/metabolism , Extracellular Matrix Proteins/metabolism , Glycoproteins/metabolism , Peptide Fragments/metabolism , Phosphoproteins/metabolism , Bone and Bones/drug effects , Bone and Bones/physiopathology , Collagen Type I/chemistry , Collagen Type I/metabolism , Crystallization , Extracellular Matrix Proteins/pharmacology , Gels/chemistry , Glycoproteins/pharmacology , Humans , Osteomalacia/genetics , Osteomalacia/metabolism , Osteomalacia/physiopathology , Peptide Fragments/pharmacology , Phosphoproteins/pharmacology , Phosphorylation/drug effects , Protein Modification, Translational/drug effects , Protein Modification, Translational/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...